Johnson & Johnson Clinical Diagnostics, Inc.: FDA filings under this applicant name
FDA lists 33 510(k) clearances under the applicant name “Johnson & Johnson Clinical Diagnostics, Inc.” (first 1995, latest 1998), across 27 product codes in 3 review panels. Median 510(k) review time under this name: 39 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under QuidelOrtho, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| JJY | Multi-Analyte Controls, All Kinds (Assayed) | 3 | 3 |
| CDP | Radioimmunoassay, Total Triiodothyronine | 2 | 2 |
| CGJ | Radioimmunoassay, Follicle-Stimulating Hormone | 2 | 2 |
| DHA | System, Test, Human Chorionic Gonadotropin | 2 | 2 |
| JLW | Radioimmunoassay, Thyroid-Stimulating Hormone | 2 | 2 |
| CDN | Urease, Photometric, Urea Nitrogen | 1 | 1 |
| CEC | Radioimmunoassay, Free Thyroxine | 1 | 1 |
| CEE | Radioimmunoassay, Thyroxine-Binding Globulin | 1 | 1 |
| CEM | Electrode, Ion Specific, Potassium | 1 | 1 |
| CEP | Radioimmunoassay, Luteinizing Hormone | 1 | 1 |
Plus 17 more product codes.
Review panels
- Clinical Chemistry (29)
- Immunology (2)
- Clinical Toxicology (2)
Most recent Johnson & Johnson Clinical Diagnostics, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K980283 | VITROS CHEMISTRY PRODUCTS CRBM SLIDES | KLT | 1998-02-25 | 30 |
| K974644 | VITROS IMMUNODIAGNOSTIC PRODUCTS RANGE VERIFIERS | JJX | 1998-01-13 | 32 |
| K973517 | VITROS IMMUNODIAGNOSTIC PRODUCTS RANGE VERIFIERS | JJY | 1997-09-25 | 8 |
| K973030 | VITROS IMMUNODIAGNOSTICS PRODUCTS/CK-MB REAGENT PACK(GEM.1300)/CK-MB CALIBRATORS (GEM.C300) | JJY | 1997-09-04 | 21 |
| K972133 | VITROS IMMUNODIAGNOSTICS PRODUCTS PROGESTERONE REAGENT PACK (GEM.1070), PROGESTERONE CALIBRATORS (GEM.C070) | JLS | 1997-06-24 | 18 |
| K970894 | VITROS IMMUNODIAGNOSTICS PRODUCTS TOTAL B-HCG REAGENT PACK (GEM.1075), TOTAL B-HCG CALIBRATORS (GEM.C075) | DHA | 1997-04-14 | 34 |
| K970643 | VITROS IMMUNODIAGNOSTICS PRODUCTS ESTRADIOL REAGENT PACK(GEM. 1050)/ESTRADIOL CALIBRATORS (GEM.C050) | CHP | 1997-03-18 | 26 |
| K965142 | VITROS IMMUNODIAGNOSTICS PRODUCTS FREE T4 REAGENT PACK (GEM.1015) FREE T4 CALIBRATORS (GEM.CO15) | CEC | 1997-03-18 | 85 |
| K970281 | VITROS IMMUNODIAGNOSTIC PRODUCTS PROLACTIN REAGENT PACK/CALIBRATORS | CFT | 1997-02-25 | 32 |
| K964982 | VITROS IMMUNODIAGNOSTICS PRODUCTS LH REAGENT PACK (GEM.1055) AND LH CALIBRATORS (GEM.CO55) | CEP | 1997-02-20 | 70 |
23 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Johnson & Johnson Clinical Diagnostics, Inc..
37 product recalls in 25 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 8 initiated in the last five years. Most often: Ortho-Clinical Diagnostics (24), Ortho-Clinical Diagnostics, Inc. (4), ORTHO-CLINICAL DIAGNOSTICS (3).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Parent company SEC filings
QuidelOrtho Corp (QDEL): EDGAR filings, CIK 1906324. Caduvo groups Johnson & Johnson Clinical Diagnostics, Inc. under QuidelOrtho; the parent's SEC registrant is entered by hand for the group, not matched by name.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Johnson & Johnson Professionals, Inc. (206 510(k)s)
- Johnson & Johnson Medical, Inc. (53 510(k)s)
- Johnson & Johnson Orthopaedics, Inc. (22 510(k)s)
- Johnson & Johnson (14 510(k)s)
- Johnson & Johnson Vision Care, Inc. (12 510(k)s)
- Johnson & Johnson International (10 510(k)s)
- Johnson & Johnson Consumer Products, Inc. (8 510(k)s)
- Johnson & Johnson Medical, Div. of Ethicon, Inc. (5 510(k)s)
- Johnson & Johnson Surgical Vision, Inc. (4 510(k)s)
- Johnson & Johnson Patient Care, Inc. (4 510(k)s)
- Johnson & Johnson Medical, Ltd. (3 510(k)s)
- Johnson & Johnson Consumer, Inc. (2 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Johnson & Johnson Clinical Diagnostics, Inc.?
FDA lists 33 510(k) clearances under the applicant name “Johnson & Johnson Clinical Diagnostics, Inc.” (first 1995, latest 1998), across 27 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Johnson & Johnson Clinical Diagnostics, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Johnson & Johnson Clinical Diagnostics, Inc. is 39 days.
Which FDA product codes appear under Johnson & Johnson Clinical Diagnostics, Inc.?
The most frequent FDA product codes under this applicant name are JJY (Multi-Analyte Controls, All Kinds (Assayed), 3); CDP (Radioimmunoassay, Total Triiodothyronine, 2); CGJ (Radioimmunoassay, Follicle-Stimulating Hormone, 2).
Next steps
- See all 33 Johnson & Johnson Clinical Diagnostics, Inc. clearances with predicates and recalls
- Run predicate analysis for product code JJY, Johnson & Johnson Clinical Diagnostics, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.